Sponsored Publications Archives - Page 20 of 20 - European Biotechnology Magazine

Stay up to date every week with the european biotechnology newsletter.

Email(Required)

This field is hidden when viewing the form

EBcom NL

confirm list

This field is hidden when viewing the form

Consent

I agree to the privacy policy.

This field is for validation purposes and should be left unchanged.

Stay up to date every week with the european biotechnology newsletter.

Email(Required)

This field is hidden when viewing the form

EBcom NL

confirm list

This field is hidden when viewing the form

Consent

I agree to the privacy policy.

Company

This field is for validation purposes and should be left unchanged.

go to the article

go back to the homepage

BIOCOM CARD
Newsletter
Advertising
Job Market
Shop

Latest news
Background
Opinion
The Mag
- Issues
- Special
- Subscribe
Euro Biotech Guide
Market Place
Associations
Service
Events
Search
Menu Menu

14 Must-Haves to Boost the Efficiency of Your Data Room

Sponsored Publications

Stop wasting time with data room software that doesn’t really improve your workflow.

17 October 2016

https://european-biotechnology.com/wp-content/uploads/2024/04/Drooms_Whitepaper.png 360 640 Maren Kühr /wp-content/uploads/2024/07/EBM_quer_Logo_2022_400px_wihte.png Maren Kühr2016-10-17 16:12:172016-10-17 16:12:1714 Must-Haves to Boost the Efficiency of Your Data Room

Humanized NSG and NSG-SGM3 mice as a new preclinical bridge for immune-oncology therapies

Sponsored Publications

Humanized NSG and NSG-SGM3 mice as a new preclinical bridge for immune-oncology therapies.

29 September 2016

https://european-biotechnology.com/wp-content/uploads/2024/04/WhitePaper_Jackson_Labs__May16_.jpg 360 640 Thomas Gabrielczyk /wp-content/uploads/2024/07/EBM_quer_Logo_2022_400px_wihte.png Thomas Gabrielczyk2016-09-29 14:43:002016-09-29 14:43:00Humanized NSG and NSG-SGM3 mice as a new preclinical bridge for immune-oncology therapies

TOP3 CHALLENGES FOR COMMERCIAL TEXT MINERS

Sponsored Publications

How Content Access and Manual Process Hinder Mining Efforts

27 September 2016

https://european-biotechnology.com/wp-content/uploads/2024/04/WhitepaperRightsEBSIN.jpg 360 640 Thomas Gabrielczyk /wp-content/uploads/2024/07/EBM_quer_Logo_2022_400px_wihte.png Thomas Gabrielczyk2016-09-27 14:45:132016-09-27 14:45:13TOP3 CHALLENGES FOR COMMERCIAL TEXT MINERS

Humanized NSG and NSG-SGM3 mice as a new preclinical bridge for immune-oncology therapies.

Sponsored Publications

14 June 2016

/wp-content/uploads/2024/07/EBM_quer_Logo_2022_400px_wihte.png 0 0 Thomas Gabrielczyk /wp-content/uploads/2024/07/EBM_quer_Logo_2022_400px_wihte.png Thomas Gabrielczyk2016-06-14 18:09:092016-06-14 18:09:09Humanized NSG and NSG-SGM3 mice as a new preclinical bridge for immune-oncology therapies.

Page 20 of 20«‹18 1920

LATEST NEWS

Marcus Krauss - stock.adobe.com

BioNTech‘s breast cancer ADC outperforms Roche...

adobe stock photo - Blackmint Studio

Alt protein: EASAC sees immediate need for action

Intestinal bacteria consortia helpcontrol intestinal digestion and the immune system

adobe stock photos - nobeastsofierce

Microbiome play MRM Health NV raises €55m in Seri...

MAGAZINE

1 / 4

This issue focuses on the art of upscaling industrial biotechnology in Europe, the impact of the Trump factor on the life sciences and the European Commission's new billion-euro fund for emerging … more ➔

2 / 4

This issue offers insights into Europe's fight for green solutions for a bioeconomy, antimicrobial resistance and how Europe is preparing for the next pandemic. more ➔

3 / 4

Since the first antibody drug was approved back in 1986, monoclonal antibodies have emerged as the dominant class in the global US$417bn market for biologics. At the end of 2023, sales stood at more … more ➔

4 / 4

The first half of 2024 is history, and experts are divided on whether the financing nadir has been reached or even passed. There are very different figures for different types of treatments under … more ➔